View source for PCC TC Face to Face July 22 26, 2019 Minutes


== '''Monday July 22, 2019''' ==

*'''Attendees'''
**In Person: Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
**Via Webex: Emma Jones (Allscripts)

*'''Review Anti-trust and Patent Policy'''

*'''Format codes'''
**Format codes IHE and HL7 have their own format codes 
**There is a lot of confusion for a vendor perspective between format codes and template ID
***Shall PCC work on a profile to manage this ?

*'''Agenda update''' see [[PCC_TC_Face_to_Face_July_22-26,_2019]]

*'''Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)'''
**Collect of all comments has been done by Emma Jones. 
**Comments will be reviewed on Tuesday 
**DCP : 3 types of comments have been received 
**CDA-DSS : comments have been received from Steve


*'''Profile proposal: IPS (International Patient Summary)'''
**Website [http://international-patient-summary.net/]
**Main editor : M Nusbaum, Andrea Fourquet, 
**Attendees: same +
***In Person: Lori Fourquet, Derek, 
***Via Webex: Michael Nusbaum
**PCC TC questions 
***1)Scope of workflow ?
***2)Benefits for vendor (risks)?
***3)Marketing?
**Next steps
***IHE PCC TC needs more detail about this proposal. 
***Is there any additional stake holder ? 
***Who is responsible of what betwenn HL7 and IHE?


== '''Tuesday July 23, 2019''' ==
*'''Attendees'''
**In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
**Via Webex: Emma Jones (Allscripts)

*'''Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)'''
**DCP public comments 
***C-01 to C08, C-10 to C-12, C-15 to C-16, C-19 to C-46: Persuasive
***C-09, C-13, C-14, C-18, C-46: Emma needs input from Jeff 
***C-47, C-48: Non persuasive
***C-49, C-52: Hold for now
***C-02: Persuasive, Content modules in PCC are in Volume 2, should be Appendix D
***C-25 to C-28: persuasive, split the use cases to simplify the diagram  to include the additional subscribe transactions
**CDA-DSS public comments
***C-01 to C-03, C-05 to C-10: persuasive
***C-04: non persuasive

*'''IPS-International Patient Summary (Profil proposal)'''
**Attendees: same +
***In Person: Lori Fourquet, Tone Southerland (IQVIA)
**There is a "general confusion" about the goal of the profile in a IHE perspective : is it a workflow profile ? a content profile ? a  test plan ? a FHIR and CDA profile ? 
**Details proposal will be presented in two weeks during the PCC T-CONF



== '''Wednesday July 24, 2019''' ==

*'''Attendees'''
**In Person: Michael Clifton (Epic), Thierry Dart (ASIP Santé)
**Via Webex: Emma Jones (Allscripts)



*'''Review of public comments : DCP (Dynamic Care Planning) and CDA-DSS (CDA Document Summary Sections)'''
**DCP public comments 
***DCP public comments will be reviewed on the next PCC T-Conf, because Emma needs some inputs from Jeff and Steve. 
 
**CDA-DSS public comments
*** All the comments have been reviewed. 



*'''Profile proposal: IPS (International Patient Summary)'''
**Attendees: same +
***In Person: Lori Fourquet, Tone Southerland (IQVIA), Derek Ritz
***Via Webed: Didi Davis, John Donnelly
**Consensus
***A detailed proposal is needed
***IHE can produce, for this cycle, a very basic document with two options: test plan or content profile (a workflow approach is too large for this cycle) 
***Agenda could be : Vol1 in November 2019, Vol2 in February 2020, Review of public comments in April 2020
**Voting session
*** 4 voting : Michael Clifton (Epic), Tone Southerland (IQVIA), John Donnelly, Thierry Dart (ASIP Santé)
*** One motion from Tone Southerland (4 in favour, 0 abstention) to have more details in a detailed proposal in a few weeks to be reviewed during PCC T-Conf (bi-weekly)


== '''Thursday July 25, 2019''' ==

*'''Joint meeting ITI, PCC, QRPH, PHARM'''


*'''QEDm update on FHIR R4 review and voting'''
** John Moehrke (ITI) has updated QEDm profile on FHIR R4
** Voting for publication in trial implementation: Andrea Fourquet, Michael Clifton (Epic), Tone Southerland (IQVIA), Thierry Dart (ASIP Santé)
*** All in favour, no abstention